MyAverix Finance
US · Healthcare
Celyad Oncology SA (CLYYF)
Biotechnology
Celyad Oncology SA (CLYYF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CLYYF
Celyad Oncology SA (CLYYF) — FAQ
What is CLYYF's P/E ratio?
The price-to-earnings (P/E) ratio for Celyad Oncology SA (CLYYF) is 18.00 (data as of 2026-03-23).
Does Celyad Oncology SA pay a dividend?
Dividend yield is not available in the current snapshot for Celyad Oncology SA (CLYYF). Check the MyAverix Finance app for the latest dividend data.
What sector is Celyad Oncology SA in?
Celyad Oncology SA (CLYYF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CLYYF listed on?
CLYYF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.